initial public offering

The UCL Technology Fund has revealed that one of its investments, MeiraGTx — a clinical stage gene therapy company — has raised $75 million of gross proceeds upon the closing of its initial public offering (IPO) earlier this year. Read more


The company's new trading ticker on the big board is CTLT. Read more